Objective: In patients with mitochondrial DNA (mtDNA) maintenance disorders and with aging, mtDNA deletions sporadically form and clonally expand within individual muscle fibers, causing respiratory chain deficiency. This study aimed to identify the sub-cellular origin and potential mechanisms underlying this process. Methods: Serial skeletal muscle cryosections from patients with multiple mtDNA deletions were subjected to subcellular immunofluorescent, histochemical, and genetic analysis. Results: We report respiratory chain-deficient perinuclear foci containing mtDNA deletions, which show local elevations of both mitochondrial mass and mtDNA copy number. These subcellular foci of respiratory chain deficiency are associated with a local increase in mitochondrial biogenesis and unfolded protein response signaling pathways. We also find that the commonly reported segmental pattern of mitochondrial deficiency is consistent with the three-dimensional organization of the human skeletal muscle mitochondrial network. Interpretation: We propose that mtDNA deletions first exceed the biochemical threshold causing biochemical deficiency in focal regions adjacent to the myonuclei, and induce mitochondrial biogenesis before spreading across the muscle fiber. These subcellular resolution data provide new insights into the possible origin of mitochondrial respiratory chain deficiency in mitochondrial myopathy.
proximal myopathy, ataxia, sensory axonal neuropathy, and optic atrophy. Genes associated with these phenotypes encode proteins involved in mtDNA replication (eg, POLG, TWNK, DNA2, MGME1), deoxyribonucleoside triphosphate supply (eg, TP, RRM2B, TK2, DGUOK), and proteins regulating mitochondrial dynamics (OPA1, MFN2). 2 Clonal expansion of mtDNA deletions is an important cause of mitochondrial respiratory chain deficiency. A critical unanswered question is where and how, within the cell cytoplasm, new mtDNA deletions expand from a single mutated mtDNA molecule to become the dominant mtDNA species. Several theoretical models have been proposed to explain the clonal expansion of mutant mtDNA. [3] [4] [5] [6] [7] [8] However, previous models were based on cell populations in vitro 9, 10 or invertebrate models with pre-existing mixtures of mutant mtDNA. 11, 12 Skeletal muscle fibers have a highly organized cytoarchitecture, where spatially restricted mitochondrial subpopulations exist. 13, 14 Subsarcolemmal (SS) mitochondria are located at the periphery of the muscle fiber adjacent to the sarcolemma membrane, a subset of which are perinuclear; whereas intermyofibrillar (IMF) mitochondria are located between the myofibrils at the Z-band. This raises the question of how clonal expansion proceeds through these highly organized and spatially restricted mitochondrial populations. To investigate this process, we sought to localize and analyze the earliest visible biochemical defect in muscle fibers from patients. Increasing our understanding of this phenomenon will provide insight into the origins of mtDNA deletions and respiratory chain deficiency, with potential diagnostic and prognostic implications.
Materials and Methods

Muscle Biopsies
Muscle biopsies from quadriceps were obtained via needle biopsy under local anesthesia. Ethical approval was granted by the Newcastle and North Tyneside local research ethics committees (reference 2002/205), and prior informed consent was obtained from each participant. Normal human ageing samples were obtained from the Hertfordshire cohort. 15 Control tissue (n = 20) was acquired with prior informed consent from people undergoing anterior cruciate ligament surgery, following approval by the Newcastle and North Tyneside local research ethics committees (reference 12/NE/0395). All experiments were carried out in accordance with the approved guidelines. Muscle samples were frozen in liquid N 2 -cooled isopentane, mounted in OCT, and stored at −80 C until use, or fixed for electron microscopy. All biopsies from mtDNA maintenance disorders (n = 7) had confirmed genetic diagnoses. Sequential cytochrome c oxidase (COX)/succinate dehydrogenase (SDH) histochemistry was used to screen biopsy specimens, and those with a suitable muscle histology and a significant degree (>2-5%) of COX deficiency (COX-SDH+) were included (Supplementary Table) . Patient selection for each experiment was based on tissue availability due to the large number of sections required for each experiment. Genetic and immunofluorescent analyses were completed on separate sections to enable high resolution quantitative fluorescent imaging in parallel with high contrast accurate laser captue microdissection.
COX/SDH Histochemistry
To quantify the prevalence of COX-deficient foci, cryosectioned muscle (10 μm) from transversely orientated muscle blocks, from mtDNA maintenance disorder patients (n = 6, Patients 1-4, 6, and 7), was subjected to sequential COX/SDH histochemistry 16 and independently analyzed by 2 investigators. Strict criteria were applied for foci quantification. Only circumscribed foci deficient in COX activity but with SDH activity (ie, COX-SDH+) that were localized in an otherwise COX-positive fiber were counted as a COX-deficient niche.
COX/SDH and Nuclear Staining
Serial 8 μm sections were subject to COX/SDH histochemistry before counterstaining with 4,6-diamidino-2-phenylindole (DAPI; D9542; Sigma, St Louis, MO; 2 μg/ml) for 5 minutes and mounting in ProLong Gold (P10144; Thermo Fisher Scientific, Waltham, MA). Images were captured in both brightfield and DAPI channels individually and merged. At least 14 serial sections were reconstructed to provide 3-dimensional information about the length of COX-deficient foci and their proximity to myonuclei.
mtDNA Deletion and Copy Number Analysis
Serial muscle sections (15 μm) treated for COX/SDH histochemistry were cryosectioned onto PEN membrane slides (#000635-17; Zeiss, Oberkochen, Germany). Patient selection for genetic analysis was based on tissue availability. Muscle fibers with regions of focal cross-sectional COX deficiency were identified, and the COX-deficient area was laser microdissected and captured into separate 0.2ml tubes using a PALM system (Zeiss). Two identically sized subsarcolemmal regions from the remainder of the muscle fiber were also captured, in addition to whole COX-positive and COX-deficient muscle fibers as controls. Muscle fibers were lysed in 15 μl single-cell lysis buffer (0.5M TrisHCl, 0.5% Tween 20, 1% proteinase K, pH 8.5) and incubated at 55 C for 3 hours followed by 10 minutes at 95 C. The lysate was then diluted 1:5 and analyzed in triplicate using a DLoop/MT-ND1/MT-ND4 triplex real-time polymerase chain reaction (PCR) deletion assay. 17 A serial dilution of the p7D1 plasmid was used to generate a standard curve from each plate. For a plate of samples to be included in analyses, an amplification efficiency of 100 to 95% was required for the standard curve. Major arc deletions were quantified by computing the ratio of MT-ND1/MT-ND4. assay, which may result from deletion of MT-ND1, are shown as zero. Due to the low mtDNA content of the foci and of the similarly sized COX-positive regions of the muscle fiber, we further implemented a stringent quality control threshold requiring all foci and corresponding regions of the same fiber to be at least three quantification cycles values below the no-template control for MT-ND1. The D-Loop region can become triple-stranded during transcription/replication, 18 so analysis of D-Loop/MT-ND1 ratios in cells that did not have deletions encompassing MT-ND1 were used to exclude this possibility. As a control, 2 to 4 fully COX-deficient and COX-positive control fibers were also run in triplicate on every plate. By these criteria, 68% of cells were eliminated due to inadequate amplification. Overall, 27 foci and their matched COX-positive regions from 5 patients with POLG (n = 2), RRM2B (n = 2), and TWNK (n = 1) mutations (Patients 2-5 and 7; see Supplementary Table) showed robust amplification and were used for subsequent analyses.
Immunofluorescence
Serial cryosections (8 μm) were subject to quantitative immunofluorescence staining. 19 
Image Analysis
The average fluorescent intensity corresponding to the abundance of an investigated protein in the muscle fibers was quantified using Image J (version 1.50i) or IMARIS v.7.7.2 (Bitplane). 19, 20 The "plot profile" functions in Image J and ZEN (blue edition) were used to compare changes in MTCOI and SDHA abundance across muscle fibers, subtracting the background fluorescence for each channel.
Immunofluorescent Assessment of Signaling Proteins
Antibodies Table) . IMARIS v.7.7.2 (Bitplane) was used to assess average fluorescent intensity of signaling markers relative to MTCOI/SDHA ratio in whole COX-positive and COX-deficient fibers. Average intensity of the foci was compared to a COX-positive region of the fiber.
Fiber Perimeter Profiling to Identify Perinuclear Domains and Regions of Mitochondrial Deficiency
Serial skeletal muscle sections were labeled for MTCOI, SDHA, and DAPI (as described above) from 3 patients with multiple mtDNA deletions (Patients 3, 5, and 7; see Supplementary  Table) . A total of 74 fibers containing foci of mitochondrial deficiency were identified by visual inspection and used for fiber section perimeter profiling. DAPI, SDHA, and MTCOI fluorescence intensity profiles were constructed. Differences in DAPI intensities between sections were minimized by subtracting the background intensity (modal, unsaturated DAPI intensity) of each section. Perinuclear perimeter domains were identified as areas with a corrected DAPI intensity greater than the 0.85 quantile of corrected intensity observed in all 74 fibers across serial sections in 3 patients. All points along intensity profiles were manually annotated as COX-positive or COX-deficient by visual inspection of perimeter profiles as well as linear line scans through the center of the muscle fiber to identify perimeter segments with mitochondrial deficiency.
Predicted and Observed Levels of FocusPerinuclear Overlap
For each section, we measured the fraction of the perimeter annotated as perinuclear (P), the fraction of the perimeter annotated as focal deficiency (F), and the fraction of the perimeter annotated as focus-perinuclear overlap (O). We also calculated the fraction of the perimeter that we would expect to be annotated as focus-perinucleus overlap if the locations of the perinuclear region and nuclei were unrelated and random (overlap predicted [O pred ]). According to the specific multiplication rule for the probability of 2 independent events co-occurring, we would expect that:
To test whether differences between O pred and observed O obs were significant, a 1-tailed t test to examine whether O pred − O obs was significantly different from zero was performed. Code August 2018 291 and data underlying profiling and overlap analysis can be found at https://github.com/lwlss/MitoDysfunctionFoci.
Serial Block Face Scanning Electron Microscopy
As described previously, serial block face scanning electron microscopy (SBF-SEM) sample preparation and imaging were performed 22 to examine the three-dimensional (3D) organization of intermyofibrillar mitochondria. Four muscle fibers from 12 muscle biopsies were imaged and 3D models assessed to determine mitochondrial distribution and anisotropy.
Statistics
A combination of 2-tailed unpaired (whole muscle fibers) and paired (matched subcellular regions) t tests was used. Statistical significance was set at 0.05. Data for focal regions of deficiency are presented as individual COX-deficient fiber regions with paired COX-positive regions. All analyses were performed in Prism v7.0 (GraphPad Software, San Diego, CA).
Results
Foci of Respiratory Chain Deficiency Are a Pathological Hallmark of mtDNA Deletions
We investigated skeletal muscle biopsies from patients with multiple mtDNA deletions due to nuclear gene mutations affecting mtDNA maintenance (n = 7; see Supplementary Table, Fig 1) . The commonly reported pattern of respiratory chain deficiency in skeletal muscle consists of a mosaic pattern of COX-positive and COX-deficient muscle fibers, with the affected muscle fibers observed in the longitudinal orientation harboring confined segments of respiratory chain deficiency (see Fig 1A) . 3, [23] [24] [25] [26] As expected, we observed COX-deficient muscle fibers in both the transverse and longitudinal orientations (see Fig  1A, B) . In addition, we identified focal regions of respiratory chain deficiency within individual muscle fibers (see Fig 1C,  D) . These foci, which had not been previously reported, were observed in patients with mitochondrial disease and normal muscle biopsies of older individuals, but not in age-matched control biopsies (n = 20). COX-deficient foci were also observed in muscle biopsies of older individuals (i.e., normal aging).
To estimate the prevalence of COX-deficient foci in specific mtDNA maintenance disorders, we surveyed cryosections reacted for sequential COX/SDH histochemistry from patients with TWNK, RRM2B, and POLG mutations (n = 6, Patients 1-4, 6, and 7). A total of 11 COX-deficient foci and 929 fully COX-deficient muscle fibers were identified (see Fig 1E) . Skeletal 
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Volume 84, No. 2 muscle biopsies contained on average 11.9% (range = 0.8-30.5%) fully COX-deficient muscle fibers, compared to 0.15% (range = 0-0.33%) with restricted COX-deficient foci (see Fig 1E) . The total prevalence of COX-deficient foci relative to total muscle fibers and fully COX-deficient muscle fibers was estimated at 1:571 and 1:58, respectively.
Focal Regions of Deficiency Are Restricted to the Subsarcolemmal Space
When surveying COX/SDH histochemistry, we consistently found that focal regions of deficiency are localized in the subsarcolemmal space (see Fig 1B-D) . This finding was corroborated by quantitative immunofluorescence (Fig 2) . 19 We generated MTCOI/SDHA intensity profiles to map the distribution of COX deficiency with subcellular resolution. The spectrum of MTCOI deficiency ranged from confined perinuclear foci to segmental and completely MTCOI-deficient muscle fibers (Fig 2A-D) . Furthermore, comparing SDHA fluorescent intensity in COX-deficient foci and COX-positive regions of the same fibers indicated that SDHA protein abundance was consistently higher by an average of 3.3-fold in MTCOIdeficient foci (see Fig 2E) , indicating a local increase of mitochondrial mass specifically in areas of respiratory chain deficiency. We verified that this increase in SDHA protein was specific to COX-deficient niches and not a result of increased mitochondrial content near the nucleus (ie, perinuclear vs subsarcolemmal) by analysis of normal muscle fibers from patients and controls (data not shown). The use of SDHA as a mitochondrial mass marker was also validated against VDAC1 (see Fig 2F) , showing that both markers yield equivalent results.
Respiratory-Deficient Foci Contain mtDNA Deletions
We next confirmed that respiratory chain-deficient foci contain higher levels of mtDNA deletions than the rest of the muscle fiber, using laser capture microdissection of August 2018 293 small subcellular areas followed by triplex real-time PCR (Fig 3) . This analysis was performed in patients with mutations in mtDNA maintenance genes POLG or RRM2B (Patients 2-5 and 7). COX-deficient foci and 2 identically sized COX-positive areas of the same muscle fiber were microdissected (see Fig 3A) . The majority of COX-deficient foci had deletions encompassing MT-ND4, and some deletions encompassing MT-ND1, whereas COX-positive areas of the same muscle fiber generally only contained normal mtDNA, or lower levels of the deletion (see Fig 3B) . On average, significantly higher mtDNA deletion levels were detected in foci compared to COX-positive regions. Less than 10% of fibers had deletions encompassing MT-ND1 (not shown), consistent with previous findings. 27 The same deletion pattern was observed in whole fibers, consistent with foci and fully deficient fibers being etiologically related.
mtDNA Copy Number and Mitochondrial Mass Is Increased in COX-Deficient Foci If increased mitochondrial biogenesis contributed to the accumulation of deleted mtDNA molecules, we reasoned that mtDNA copy number should similarly be elevated in the respiratory chain-deficient foci compared to COX-positive regions of the same cell. Therefore, we measured absolute mtDNA copy number density in COX-deficient foci relative to corresponding COX-positive regions of the same fibers, using an optimized standard curve method. 17 Because MT-ND4 and occasionally MT-ND1 can both be deleted in human skeletal muscle, 27 we used D-Loop and MT-ND1
amplicons as metrics of copy number. Consistent with the elevation in mitochondrial protein content (see Fig 2E) , mtDNA copy number was increased in the majority of COX-deficient foci (see Fig 3C-D) . Isolated COX-deficient foci relative to COX- 
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Volume 84, No. 2 positive regions showed a mean 2.2-fold higher (range = 1.1-9.6, p < 0.001) D-Loop copy number. This was confirmed by MT-ND1 copy number, where the within-fiber difference between COX-deficient and COXpositive regions was 2.5-fold (range = 1.1-11.7, p < 0.001). In comparison, cells with complete COX deficiency showed on average a 1.9-fold (range = 1.0-6.5, p = 0.03) higher D-Loop copy number and 1.9-fold (range = 1.0-6.2, p = 0.03) higher MT-ND1 copy number compared to cells with normal COX activity (see Fig 3E) . Thus, COX-deficient foci are associated with local upregulation of mtDNA copy number and mass.
Accumulation of COX-Deficient Mitochondrial Mass Occurs Near Myonuclei
Mitochondrial biogenesis is dependent on several nuclear encoded proteins; therefore, we hypothesized that the localization of COX-deficient mutant niches in the subsarcolemmal space may be due to the presence of myonuclei. Thus, serial sections were subjected to COX/SDH histochemistry counterstained with DAPI to determine the focal distribution and topology of COX-deficient foci in relation to the myonuclei along the length of muscle fibers (Fig 4A) . Immunofluorescent labeling of serial sections for MTCOI/ SDHA/DAPI objectively confirmed the colocalization of COX-deficient niches with myonuclei (see Fig 4B, C) . To identify COX-deficient foci that did not colocalize with nuclei, we profiled perinuclear regions and MTCOI fluorescent intensity along the perimeters of fiber sections containing a region of COX deficiency. Perinuclear regions were identified automatically by thresholding DAPI signal along the perimeter. Focal regions of COX deficiency were manually classified by visual inspection of SDHA and MTCOI profiles along the perimeter (see Fig  4D, E) and by line scan quantification as in Figure 2 . Across 74 fiber sections containing COX-deficient foci, 26.2% of the perimeter was classified as perinuclear and 20.0% was classified as COX-deficient foci. Given the relative proportions of perinuclear space and focal deficiency, if the location of nuclei and COX-deficient foci were unrelated (ie, random), we would expect only 5.23% of the perimeter to be classified as overlap. In contrast, 9.5% was classified as COX-deficient foci and perinuclear overlap. To determine the significance of this difference, in each muscle fiber the observed overlap was measured and the predicted foci-nuclei overlap was calculated.
The differences between predicted and observed overlap fractions were found to be significantly lower than zero (p = 4.26e −15 ; see Fig 4F, G) . A total of 75 distinct foci were identified in 74 cells, all of which at least partially overlapped with a perinuclear region, consistent with the required presence of a nucleus for clonal expansion of mutant mitochondria.
Localized Activation of Mitonuclear Signaling Pathways with mtDNA Deletions
To assess whether signaling may be contributing to the increased mitochondrial content and mtDNA deletions in the perinuclear niche, we probed markers of (1) mitochondrial biogenesis, (2) mitochondrial unfolded protein response (UPR mt ), and (3) mitophagy (Fig 5) . We analyzed the mitochondrial biogenesis marker TFAM, UPR mt marker Hsp60, retrograde signaling factor GPS2, 28 and mitophagy marker Beclin1. COX-deficient foci, representing early stage respiratory chain deficiency, were compared to equivalent size COX-positive regions of the same fibers.
Fully COX-deficient fibers, representing the late stage respiratory chain deficiency, were compared to COXpositive fibers.
Relative to COX-positive regions of individual muscle fibers, Hsp60 and GPS2 were both higher in focal regions of deficiency for 89.6% and 86.2% of foci, respectively (see Fig 5B) . Both the UPR mt and GPS2 retrograde signaling pathways have been shown to be upstream of mitochondrial biogenesis. 12,28 Accordingly, mitochondrial TFAM was also increased for 70% of foci relative to COX-positive regions. In fully COX-deficient fibers, Hsp60 and GPS2 were also significantly increased relative to COX-positive fibers (see Fig 5C) . TFAM was significantly elevated in fully COX-deficient fibers, consistent with the overall increase in mtDNA copy number in late stage COX-deficient fibers.
To verify that these results were not driven by the proximity of foci to nuclei in the SS area, we also analyzed COX-positive perinuclear regions from COX-positive fibers of patients and controls, which were compared to subsarcolemmal but nonperinuclear regions. We found that Hsp60 and TFAM levels were similar; however, GPS2 was elevated in perinuclear regions, consistent with its role as nuclear transcription factor. 28 In patient muscle, compared to perinuclear COX-positive areas, Hsp60 (2.2-fold), GPS2 (1.2-fold), and TFAM (1.5-fold) levels were all higher in COX-deficient niches, confirming the specificity of this finding.
A reduction in quality control processes to remove mutant mitochondria via autophagy could also have contributed to the accumulation of mutant mitochondria in specific subcellular compartments. Immunolabeling of the autophagic regulator Beclin1 29 showed that levels were unchanged in COX-deficient foci, although significantly higher in fully COX-deficient fibers (see Fig 5B, C) , with no difference between the SS and IMF region.
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Respiratory Chain Deficiency First Spreads in Cross-Section following Mitochondrial Network Anisotropy Finally, we sought to address whether mitochondrial network connectivity may dictate the segmental appearance of respiratory chain deficiency (Fig 6) . Examining muscle fibers longitudinally revealed the existence of strikingly short COX-deficient muscle fiber segments, where the diameter of the COX-deficient muscle fibers is substantially wider than the longitudinal axis.
In skeletal muscle cells, intermyofibrillar mitochondria organized at the Z-bands show a substantial degree of branching. We examined the 3-dimensional morphology of skeletal muscle mitochondria in human controls (n = 8) and patients (n = 6) using SBF-SEM (see Fig 6C, D) . Controls and patients both demonstrate high mitochondrial connectivity across the transverse orientation of each muscle fiber and low connectivity between Z-bands along the muscle fiber; representative images are shown in Figure 6D . These results support the mitochondrial network model and likely provide the structural basis for the segmental COX deficiency regularly observed in mitochondrial myopathy and aging. 30 Foci Are Observed in Aging and Other Neuromuscular Conditions In addition to mtDNA maintenance disorders, we sought to determine whether foci of deficiency are observed in other myopathies in which de novo mtDNA deletions and COX deficiency are also found. COX-deficient foci were also identified in cases of single, large-scale mtDNA deletions, inclusion body myositis, and mechanically ventilated diaphragm, where COX deficiency is associated with mtDNA deletions (Fig 7) . 26 Furthermore, muscle from healthy adults 68 to 77 years of age (n = 79) also contained COX-deficient foci, which suggested that the observation is not specific to mitochondrial myopathy but is likely relevant to other age-related myopathic conditions. 
Discussion
Mitochondrial respiratory chain deficiency in mtDNA maintenance disorders is dependent on the progressive accumulation of mtDNA deletions. Several theories have been proposed to explain the clonal expansion of mtDNA deletions. [4] [5] [6] [7] However, a number of questions remain. In postmitotic muscle fibers, where do mtDNA deletions originate? How do deleted mtDNA molecules accumulate to higher levels than wild-type mtDNA? What dictates the directional spread of respiratory chain-deficient segments along muscle fibers?
To explore these questions, we performed in-depth imaging and molecular studies of skeletal muscle biopsies from patients with genetically confirmed mtDNA maintenance disorders. We targeted the smallest portion of the muscle fiber presenting with COX deficiency and found that these areas are always perinuclear. In addition, we have shown that there is accumulation of mtDNA deletions in the COX-deficient foci along with corresponding increase in nuclear-mitochondrial signaling. Therefore, we propose that mtDNA deletions arise and accumulate within the perinuclear mitochondria, where nuclear proximity of mtDNA deletions and local induction of biogenesis are key factors for clonal expansion.
Nuclear Proximity as a Determining Factor in Focal COX Deficiency Three factors could contribute to explain why mtDNA deletions and respiratory chain deficiency originate in perinuclear mitochondria: (1) increased mutation rate in the perinuclear area, (2) higher replication rates in the perinuclear area, or (3) proximity to the nucleus for retrograde mitonuclear signaling. Davis and Clayton 31 have previously demonstrated that mtDNA replication rate is higher in the perinuclear region compared to the rest of the cell, consistent with the requirement of nuclear gene products for mitochondrial biogenesis. In patients harboring mutations in nuclear DNA genes encoding mtDNA replication machinery, a higher local replication rate could account for a higher mutation rate among perinuclear mitochondria. Thus, it is also possible that there may be multiple deletion species competing within a single focus and that the chance of mtDNA deletions being replicated in the perinuclear region may also be higher, due to the higher replication rate.
Furthermore, our data demonstrate that focal regions of COX deficiency have elevated mitochondrial mass and mtDNA copy number concomitant with higher levels of mitonuclear signaling factors, indicative of mitochondrial biogenesis through mitonuclear "retrograde" signaling. In 
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Caenorhabditis elegans, mtDNA deletions trigger nuclear activation of the unfolded protein response (UPR mt ) to promote mitochondrial biogenesis and mitochondrial dynamics. 11, 12 With mtDNA deletions existing throughout the worm from birth, this process may increase mtDNA heteroplasmy. 11, 12 The UPR mt has also been shown to modulate both biogenesis and mitophagy levels. 11, 12 Therefore, given the observations in C. elegans, it is possible that the UPR mt in foci of human muscle may be linked with activation of mitochondrial biogenesis. Our data in human skeletal muscle suggest a role for the UPR mt and possibly implicate other factors such as GPS2, which transcriptionally activates mitochondrial biogenesis in response to mitochondrial stress or depolarization. 28 Beclin1
labeling suggests no change in mitophagy in small foci representing the early stage of deficiency. However, although Beclin 1 was the only target for which antibodies of sufficient quality on frozen muscle samples was available, Beclin1 may not reflect all mitophagy pathways. Based on the differential upregulation of signaling factors in focal COX-deficient and fully COXdeficient fibers, it remains possible that multiple signaling pathways are activated at different stages of expansion and in different fibers types. Clinically meaningful models will be required to generate mechanistic data and fully resolve these questions.
Focal Deficiency, Clonal Expansion, and Mitochondrial Disease Progression In addition to representing a novel pathological feature of mtDNA maintenance disorders, focal regions of deficiency were also observed in muscle from patients with single, large-scale mtDNA deletions and in normal aging. Segmental respiratory chain deficiency in longitudinal muscle fibers is a pathological hallmark of mitochondrial myopathy and aging. 3, 24, 30 To our knowledge, this is the first study to report circumscribed cytoplasmic areas of COX deficiency smaller than the diameter of muscle fibers. Our data also demonstrate that, in a muscle section, foci are relatively infrequent compared to fully COX-deficient muscle fibers. Furthermore, although COX-deficient segments in longitudinal orientation have been known to vary greatly in length, this is the first report demonstrating segments that are substantially shorter than the width of the muscle fiber (see Fig 6B) . Applying SBF-SEM analysis for the first time in human muscle confirmed the substantially more elaborate nature of the mitochondrial network along Z-bands (ie, Iband mitochondria) in the transverse orientation of human muscle fibers, compared to sparse longitudinal interconnections between sarcomeric planes (see Fig 6D) . This is in contrast to the almost continuous mitochondrial network previously reported in mice. 32 Because contiguous mitochondria can exchange (mutant) mtDNA through fusion, the anisotropic nature of the human mitochondrial network may account for COX-deficient segments that appear restricted along the length of affected muscle fibers.
Conclusions and Proposed Model
Based on our observations, we propose the following model. mtDNA deletions that arise in the perinuclear region preferentially accumulate under the influence of mitochondrial biogenesis, reaching critical mass and causing the first visible signs of focal mitochondrial respiratory chain deficiency. Mutant mitochondria then preferentially propagate transversely via direct physical interactions between mitochondria, driven in part by increased local mitochondrial biogenesis triggered by retrograde signaling from mutant mitochondria to the surrounding nucleus. The clonal nature of these deletions and the role that mtDNA replication plays in this process remain to be investigated. This hypothesis assumes that fully COX-deficient cells (which must have a point of origin) are derived from the spread of small proliferative perinuclear foci. Human-relevant disease models where this pathogenic process can be observed over time will be needed to confirm this mechanism, and to determine if it can be targeted therapeutically to prevent the clonal accumulation of mtDNA defects.
